Cannabidiol
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cannabidiol and local guidelines before prescribing.
Anticonvulsant
Mechanism
Anticonvulsant with unclear mechanism.
Uses
Dravet and Lennox-Gastaut syndromes, tuberous sclerosis seizures.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Drowsiness, diarrhoea, reduced appetite, raised transaminases.
Interactions
Raises clobazam levels; valproate increases hepatotoxicity.
Contraindications and cautions
Hepatic impairment
Monitoring
LFT, mood
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Reduce dose in moderate to severe hepatic impairment
Overdose and reversal
Supportive
Special advice
LFT monitoring at baseline and early.
More from the textbook: uses, cautions and other points
- Cannabidiol , stiripentol and fenfluramine (echocardiography) - specialist use in Dravet and Lennox–Gastaut syndromes.
Neurology: Anatomy, Physiology and Pharmacology - Dravet syndrome | SCN1A gene; prolonged fever-related seizures in infancy. Avoid sodium-channel blockers (carbamazepine, lamotrigine). Cannabidiol and fenfluramine
Neurology: Epilepsy - Dravet syndrome | SCN1A mutation; prolonged febrile and afebrile seizures from the first year, then developmental slowing. Avoid sodium channel blockers (carbamazepine, lamotrigine, phenytoin). Valproate, clobazam, stiripentol, fenfluramine, cannabidiol.
Paediatrics: Neurology, bones and joints in children - Tonic or atonic | Valproate (males), lamotrigine; specialist options (rufinamide, cannabidiol)
Neurology: Epilepsy - Newer drugs (e.g. cenobamate , perampanel, brivaracetam; cannabidiol and fenfluramine for specific syndromes).
Neurology: Epilepsy - Drug-resistant epilepsy (failure of two suitable drugs) - refer to tertiary epilepsy services: ketogenic diet, epilepsy surgery, vagus nerve stimulation, cannabidiol (in Dravet and Lennox–Gastaut).
Paediatrics: Neurology, bones and joints in children - Lennox–Gastaut syndrome | Onset 1–8 years; multiple seizure types (tonic, atonic "drop attacks", atypical absences); learning disability; EEG - slow spike and wave. Hard to treat - valproate, lamotrigine, rufinamide, cannabidiol, ketogenic diet.
Paediatrics: Neurology, bones and joints in children
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Neurology: Epilepsy (3 mentions)
- Paediatrics: Neurology, bones and joints in children (3 mentions)
- Integrated paediatrics chapter (3 mentions)